All lobbying filings

Bristol-Myers Squibb Company

Bristol-Myers Squibb Company filed a Q1 report for Bristol-Myers Squibb Company on April 20, 2025.

Lobbying for Bristol-Myers Squibb Company

As filed: BRISTOL-MYERS SQUIBB COMPANY for BRISTOL-MYERS SQUIBB COMPANY.

All filings by Bristol-Myers Squibb Company · Everything Bristol-Myers Squibb Company has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 20, 2025

Expenses

$870,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 5

Health Issues

Discussions regarding promoting health equity International Reference Pricing/Most Favored Nation, regarding all bio-pharmaceutical issues Ensuring Pathways to Innovation Cures (EPIC) Act Implementation of Inflation Reduction Act of 2022 MINI Act ORPHAN Act Mental Health Appropriations Language FY26

Medicare/Medicaid

Issues related to the 340B Drug Pricing Program - regarding all bio-pharmaceutical related provisions H.R.7635, the 340B PATIENTS Act

Taxation/Internal Revenue Code

Proposed policies regarding corporate tax reform - regarding all bio-pharmaceutical related provisions Discussions regarding OECD implementation

Intellectual Property Reform concerning bio-pharmaceutical industry

Pharmacy

H.R.830, HELP Copays Act of 2023 S.127, Pharmacy Benefit Manager Transparency Act of 2023 H.R.3283, Fairness for Patient Medications Act S.1339, Pharmacy Benefit Manager Reform Act H.R.5378, Lower Costs, More Transparency Act S.2973, Modernizing and Ensuring Equity Act H.R.8412, Clinical Trials Modernization Act

Bills named in this filing 8

H.R. 7635
The 340B PATIENTS Act of 2024
H.R. 830
HELP Copays Act
S. 127
Pharmacy Benefit Manager Transparency Act of 2023
H.R. 3283
FARMER Act
S. 1339
Pharmacy Benefit Manager Reform Act
H.R. 5378
Lower Costs, More Transparency Act
S. 2973
Modernizing and Ensuring PBM Accountability Act
H.R. 8412
Clinical Trial Modernization Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.